Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massar

Showing results (241-250 of 300) with videos related to

Pageof 30
Sort By:
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trialJulie Hempel Larsen, Massar Omar, Jesper Jensen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2021
Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)Manan Pareek, Muthiah Vaduganathan, Christina Byrne, et al.
Nature|April 16, 2010
Random numbers certified by Bell's theoremS Pironio, A Acín, S Massar, et al.
Cardiovascular Diabetology|February 27, 2022
The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker)Massar Omar, Jesper Jensen, Caroline Kistorp, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|September 26, 2024
Sentiment Analysis of Twitter Posts Related to a COVID-19 Test & Trace Program in NYCKrystle A Tsai, Michelle M Chau, Juncheng Wang, et al.
Circulation. Heart Failure|November 8, 2021
Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical TrialMassar Omar, Jesper Jensen, Daniel Burkhoff, et al.
European Journal of Heart Failure|May 23, 2022
Sex and central obesity in heart failure with preserved ejection fractionHidemi Sorimachi, Kazunori Omote, Massar Omar, et al.
Social Psychiatry and Psychiatric Epidemiology|April 4, 2024
Socioeconomic inequalities in psychosocial well-being among adolescents under the COVID-19 pandemic: a cross-regional comparative analysis in Hong Kong, mainland China, and the NetherlandsGary Ka-Ki Chung, Xiaoting Liu, Karlijn Massar, et al.
European Journal of Heart Failure|December 29, 2023
Clinical phenogroup diversity and multiplicity: Impact on mechanisms of exercise intolerance in heart failure with preserved ejection fractionKathryn Larson, Massar Omar, Hidemi Sorimachi, et al.
Frontiers in Genetics|July 20, 2023
Impact of <i>Plasmodium falciparum</i> infection on DNA methylation of circulating immune cellsDareen Almojil, Aïssatou Diawara, Issiaka Soulama, et al.
Pageof 30

Showing results (241-250 of 300) with videos related to

Sort By:
Pageof 30
American Heart Journal Plus : Cardiology Research and Practice|March 21, 2024
Influence of angiotensin receptor-neprilysin inhibition on the efficacy of Empagliflozin on cardiac structure and function in patients with chronic heart failure and a reduced ejection fraction: The Empire HF trialJulie Hempel Larsen, Massar Omar, Jesper Jensen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 13, 2021
Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)Manan Pareek, Muthiah Vaduganathan, Christina Byrne, et al.
Nature|April 16, 2010
Random numbers certified by Bell's theoremS Pironio, A Acín, S Massar, et al.
Cardiovascular Diabetology|February 27, 2022
The effect of empagliflozin on growth differentiation factor 15 in patients with heart failure: a randomized controlled trial (Empire HF Biomarker)Massar Omar, Jesper Jensen, Caroline Kistorp, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|September 26, 2024
Sentiment Analysis of Twitter Posts Related to a COVID-19 Test & Trace Program in NYCKrystle A Tsai, Michelle M Chau, Juncheng Wang, et al.
Circulation. Heart Failure|November 8, 2021
Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical TrialMassar Omar, Jesper Jensen, Daniel Burkhoff, et al.
European Journal of Heart Failure|May 23, 2022
Sex and central obesity in heart failure with preserved ejection fractionHidemi Sorimachi, Kazunori Omote, Massar Omar, et al.
Social Psychiatry and Psychiatric Epidemiology|April 4, 2024
Socioeconomic inequalities in psychosocial well-being among adolescents under the COVID-19 pandemic: a cross-regional comparative analysis in Hong Kong, mainland China, and the NetherlandsGary Ka-Ki Chung, Xiaoting Liu, Karlijn Massar, et al.
European Journal of Heart Failure|December 29, 2023
Clinical phenogroup diversity and multiplicity: Impact on mechanisms of exercise intolerance in heart failure with preserved ejection fractionKathryn Larson, Massar Omar, Hidemi Sorimachi, et al.
Frontiers in Genetics|July 20, 2023
Impact of <i>Plasmodium falciparum</i> infection on DNA methylation of circulating immune cellsDareen Almojil, Aïssatou Diawara, Issiaka Soulama, et al.
Pageof 30